Christopher Daugherty to Clinical Trials as Topic
This is a "connection" page, showing publications Christopher Daugherty has written about Clinical Trials as Topic.
Connection Strength
0.923
-
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol. 2008 Mar 10; 26(8):1371-8.
Score: 0.184
-
Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials. J Clin Oncol. 2007 Aug 10; 25(23):3488-94.
Score: 0.179
-
Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation. J Clin Oncol. 2006 Oct 20; 24(30):4793-5.
Score: 0.169
-
Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials. JCO Oncol Pract. 2020 01; 16(1):e56-e63.
Score: 0.104
-
Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol. 1999 May; 17(5):1601-17.
Score: 0.101
-
Hope and the limits of research. Hastings Cent Rep. 1996 Sep-Oct; 26(5):20; discussion 20-2.
Score: 0.084
-
Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients. Psychooncology. 2017 Oct; 26(10):1604-1610.
Score: 0.082
-
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017 02 01; 123(3):476-484.
Score: 0.021